Digital therapy for chronic tic disorders and Tourette syndrome: early value assessment

  • Health technology evaluation
  • HTE25
  • Published: 

Register as a stakeholder

Download (PDF)

Evidence generation plan for digital therapy for chronic tic disorders and Tourette syndrome: Neupulse

4 Monitoring

The developer must contact NICE:

  • within 6 months of publication of this plan to confirm agreements are in place to generate the evidence

  • annually to confirm that the data is being collected and analysed as planned.

The developer should tell NICE as soon as possible about anything that may affect ongoing evidence generation, including:

  • any substantial risk that the evidence will not be collected as planned

  • new safety concerns

  • the technology significantly changing in a way that affects the evidence generation process.

If data collection is expected to end later than planned, the developer should contact NICE to arrange an extension to the evidence generation period. NICE reserves the right to withdraw the guidance if data collection is delayed, or if it is unlikely to resolve the evidence gaps.

This page was last updated: